Mark Rush
Advertisement
Mark is a partner and associate in Kirkpatrick & Lockhart, www.kl.com, a national law firm experienced in complex commercial litigation, intellectual property enforcement, and regulatory practice
Articles by Mark Rush
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
3
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
4
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
5

